Skip to the page

Data / Form D filings / PinkDx, Inc.

PinkDx, Inc.: Form D filing

PinkDx, Inc., a biotechnology company in Indianapolis, IN, filed a Form D with the SEC in 2023. The latest, on October 20, 2023, reports $17 million sold of a $40 million offering to 7 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
ONE INDIANA SQUARE, SUITE 3500, Indianapolis, IN, 46204
Phone
(760) 889-7755
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2022
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1997642

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Oct 20, 2023New notice$40,000,048$16,984,994$23,015,0547Sep 29, 2023sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Timothy McMeekanDirector
Joe C Cook, IIIDirector
Giulia C KennedyExecutive Officer
Isaac RoDirector
Risa StackDirector
Eric C WangExecutive Officer
Bonnie AndersonExecutive Officer

Other biotechnology companies in Indiana that filed recently

Every Form D from the week of Oct 16, 2023 · All recent filings in Indiana · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what PinkDx, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.